| Keywords: |
cancer chemotherapy; leukemia; hydroxyurea; prednisone; review; fluorouracil; antineoplastic agents; cytarabine; drug inhibition; cancer immunotherapy; cell growth; tumor differentiation; dexamethasone; cell differentiation; calcitriol; carcinogenesis; daunorubicin; dactinomycin; bleomycin; mitomycin c; isotretinoin; drug therapy; therapy; colony-stimulating factors; differentiation; phorbol 13 acetate 12 myristate; tetradecanoylphorbol acetate; myeloid leukemia; retinoids; colony stimulating factor; acetamides; human; lymphokines; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; blood and hemopoietic system
|
